← Back to Search

Laser Therapy

1064nm Q-switch Laser for Melanosis

N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 10
Awards & highlights

Study Summary

The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Analog Scale (VAS) of Improvement Rated by a Blinded Dermatologist From at Week 10

Trial Design

2Treatment groups
Active Control
Group I: 1064nm Q-switch LaserActive Control1 Intervention
The 1064 Q-Switch Laser is a medical device that uses a focused laser to remove dark pigment (color) from the skin.
Group II: Glycolic Acid PeelsActive Control1 Intervention
A Glycolic Acid Chemical Peel is a mild skin treatment used to correct uneven texture and color by removing dead cells from the skin's outermost layer.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,605 Previous Clinical Trials
916,379 Total Patients Enrolled
3 Trials studying Melanosis
53 Patients Enrolled for Melanosis
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,560 Total Patients Enrolled
3 Trials studying Melanosis
53 Patients Enrolled for Melanosis
~2 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top